• Press

Press

Representatives of the press who wishes to learn more about Counterstroke are asked to kindly use the contact form above

Pressrelease

""It is a great honor to be part of the COUNTERSTROKE consortium and we are deeply impressed by the knowledge and capacity of our collaborators. It is a privilege to contribute with drug discovery and development competence in this prestigious project",

David Bejker, CEO of Affibody

Project details


Project reference: 602354
Status: Execution

Total cost: EUR 7 843 758
EU contribution: EUR 5 989 631

Programme acronym:
FP7-HEALTH

Subprogramme area:
HEALTH.2013.2.4.2-1

Contract type:
Small or medium-scale focused research project